Changing pattern of the genetic diversities of Plasmodium falciparum merozoite surface protein-1 and merozoite surface protein-2 in Myanmar isolates.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
16 Jul 2019
Historique:
received: 15 05 2019
accepted: 09 07 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 12 11 2019
Statut: epublish

Résumé

Plasmodium falciparum merozoite surface protein-1 (PfMSP-1) and -2 (PfMSP-2) are major blood-stage vaccine candidate antigens. Understanding the genetic diversity of the genes, pfmsp-1 and pfmsp-2, is important for recognizing the genetic structure of P. falciparum, and the development of an effective vaccine based on the antigens. In this study, the genetic diversities of pfmsp-1 and pfmsp-2 in the Myanmar P. falciparum were analysed. The pfmsp-1 block 2 and pfmsp-2 block 3 regions were amplified by polymerase chain reaction from blood samples collected from Myanmar patients who were infected with P. falciparum in 2013-2015. The amplified gene fragments were cloned into a T&A vector, and sequenced. Sequence analysis of Myanmar pfmsp-1 block 2 and pfmsp-2 block 3 was performed to identify the genetic diversity of the regions. The temporal genetic changes of both pfmsp-1 and pfmsp-2 in the Myanmar P. falciparum population, as well as the polymorphic diversity in the publicly available global pfmsp-1 and pfmsp-2, were also comparatively analysed. High levels of genetic diversity of pfmsp-1 and pfmsp-2 were observed in the Myanmar P. falciparum isolates. Twenty-eight different alleles of pfmsp-1 (8 for K1 type, 14 for MAD20 type, and 6 for RO33 type) and 59 distinct alleles of pfmsp-2 (18 for FC27, and 41 for 3D7 type) were identified in the Myanmar P. falciparum population in amino acid level. Comparative analyses of the genetic diversity of the Myanmar pfmsp-1 and pfmsp-2 alleles in the recent (2013-2015) and past (2004-2006) Myanmar P. falciparum populations indicated the dynamic genetic expansion of the pfmsp-1 and pfmsp-2 in recent years, suggesting that a high level of genetic differentiation and recombination of the two genes may be maintained. Population genetic structure analysis of the global pfmsp-1 and pfmsp-2 also suggested that a high level of genetic diversity of the two genes was found in the global P. falciparum population. Despite the recent remarkable decline of malaria cases, the Myanmar P. falciparum population still remains of sufficient size to allow the generation and maintenance of genetic diversity. The high level of genetic diversity of pfmsp-1 and pfmsp-2 in the global P. falciparum population emphasizes the necessity for continuous monitoring of the genetic diversity of the genes for better understanding of the genetic make-up and evolutionary aspect of the genes in the global P. falciparum population.

Sections du résumé

BACKGROUND BACKGROUND
Plasmodium falciparum merozoite surface protein-1 (PfMSP-1) and -2 (PfMSP-2) are major blood-stage vaccine candidate antigens. Understanding the genetic diversity of the genes, pfmsp-1 and pfmsp-2, is important for recognizing the genetic structure of P. falciparum, and the development of an effective vaccine based on the antigens. In this study, the genetic diversities of pfmsp-1 and pfmsp-2 in the Myanmar P. falciparum were analysed.
METHODS METHODS
The pfmsp-1 block 2 and pfmsp-2 block 3 regions were amplified by polymerase chain reaction from blood samples collected from Myanmar patients who were infected with P. falciparum in 2013-2015. The amplified gene fragments were cloned into a T&A vector, and sequenced. Sequence analysis of Myanmar pfmsp-1 block 2 and pfmsp-2 block 3 was performed to identify the genetic diversity of the regions. The temporal genetic changes of both pfmsp-1 and pfmsp-2 in the Myanmar P. falciparum population, as well as the polymorphic diversity in the publicly available global pfmsp-1 and pfmsp-2, were also comparatively analysed.
RESULTS RESULTS
High levels of genetic diversity of pfmsp-1 and pfmsp-2 were observed in the Myanmar P. falciparum isolates. Twenty-eight different alleles of pfmsp-1 (8 for K1 type, 14 for MAD20 type, and 6 for RO33 type) and 59 distinct alleles of pfmsp-2 (18 for FC27, and 41 for 3D7 type) were identified in the Myanmar P. falciparum population in amino acid level. Comparative analyses of the genetic diversity of the Myanmar pfmsp-1 and pfmsp-2 alleles in the recent (2013-2015) and past (2004-2006) Myanmar P. falciparum populations indicated the dynamic genetic expansion of the pfmsp-1 and pfmsp-2 in recent years, suggesting that a high level of genetic differentiation and recombination of the two genes may be maintained. Population genetic structure analysis of the global pfmsp-1 and pfmsp-2 also suggested that a high level of genetic diversity of the two genes was found in the global P. falciparum population.
CONCLUSION CONCLUSIONS
Despite the recent remarkable decline of malaria cases, the Myanmar P. falciparum population still remains of sufficient size to allow the generation and maintenance of genetic diversity. The high level of genetic diversity of pfmsp-1 and pfmsp-2 in the global P. falciparum population emphasizes the necessity for continuous monitoring of the genetic diversity of the genes for better understanding of the genetic make-up and evolutionary aspect of the genes in the global P. falciparum population.

Identifiants

pubmed: 31311565
doi: 10.1186/s12936-019-2879-7
pii: 10.1186/s12936-019-2879-7
pmc: PMC6636015
doi:

Substances chimiques

Antigens, Protozoan 0
Merozoite Surface Protein 1 0
Protozoan Proteins 0
merozoite surface protein 2, Plasmodium 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

241

Subventions

Organisme : 2018M3A9H5055614
ID : 2018M3A9H5055614

Références

Acta Trop. 2000 Jan 5;74(1):51-61
pubmed: 10643908
Nat Med. 2000 Jun;6(6):689-92
pubmed: 10835687
Ann Trop Med Parasitol. 2001 Mar;95(2):117-32
pubmed: 11299119
Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):163-71
pubmed: 12467983
Gene. 2003 Jan 30;304:65-75
pubmed: 12568716
Malar J. 2003 May 9;2:12
pubmed: 12773207
Parasite Immunol. 2003 Jun;25(6):307-12
pubmed: 14507328
Vaccine. 2003 Dec 8;22(1):30-41
pubmed: 14604568
Mol Microbiol. 2004 Apr;52(1):159-68
pubmed: 15049818
Parasitol Today. 1994 May;10(5):182-4
pubmed: 15275468
Parasitol Today. 1993 Feb;9(2):50-4
pubmed: 15463703
Vaccine. 2006 May 8;24(19):4233-46
pubmed: 16111789
Infect Immun. 2006 Feb;74(2):1313-22
pubmed: 16428781
Gene. 2006 Jul 19;376(2):224-30
pubmed: 16716539
Exp Parasitol. 2007 Jan;115(1):32-40
pubmed: 16797008
Vaccine. 2009 Mar 4;27(10):1651-60
pubmed: 19038302
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Malar J. 2010 May 17;9:131
pubmed: 20478015
Immunol Today. 1991 Mar;12(3):A68-71
pubmed: 2069680
PLoS Negl Trop Dis. 2011 Dec;5(12):e1424
pubmed: 22206027
Mol Ecol. 2013 Jan;22(2):273-85
pubmed: 23121253
Malar J. 2012 Nov 26;11:391
pubmed: 23181845
Vaccine. 2013 Feb 18;31(9):1334-9
pubmed: 23295064
Malar J. 2014 Jan 23;13:26
pubmed: 24456636
Parasitology. 2014 Jun;141(7):880-90
pubmed: 24533989
Lancet Infect Dis. 2015 Apr;15(4):415-21
pubmed: 25704894
Malar J. 2015 Feb 14;14:78
pubmed: 25888891
Infect Genet Evol. 2016 Nov;45:90-94
pubmed: 27562334
Malar J. 2016 Oct 18;15(1):503
pubmed: 27756394
Malar J. 2017 Mar 16;16(1):119
pubmed: 28302168
Parasit Vectors. 2017 Jul 4;10(1):322
pubmed: 28676097
Acta Trop. 2018 Feb;178:27-33
pubmed: 28993182
Malar J. 2018 Jan 2;17(1):1
pubmed: 29291736
Malar J. 2018 Feb 07;17(1):71
pubmed: 29415731
Parasit Vectors. 2018 May 30;11(1):323
pubmed: 29843783
Parasit Vectors. 2018 Aug 6;11(1):455
pubmed: 30081943
Malar J. 2018 Oct 12;17(1):361
pubmed: 30314440
J Mol Biol. 1987 May 20;195(2):273-87
pubmed: 3079521
Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):171-7
pubmed: 6151681
Mol Biochem Parasitol. 1993 May;59(1):1-14
pubmed: 8515771
Am J Trop Med Hyg. 1998 Apr;58(4):406-13
pubmed: 9574783
Mem Inst Oswaldo Cruz. 1998 Sep-Oct;93(5):631-8
pubmed: 9830530

Auteurs

Hương Giang Lê (HG)

Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea.
BK21Plus Team for Anti-aging Biotechnology and Industry, Department of Convergence Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea.

Jung-Mi Kang (JM)

Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea.
BK21Plus Team for Anti-aging Biotechnology and Industry, Department of Convergence Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea.

Hojong Jun (H)

Department of Tropical Medicine, and Inha Research Institute for Medical Sciences, Inha University College of Medicine, Incheon, 22212, Republic of Korea.

Jinyoung Lee (J)

Department of Tropical Medicine, and Inha Research Institute for Medical Sciences, Inha University College of Medicine, Incheon, 22212, Republic of Korea.

Thị Lam Thái (TL)

Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea.
BK21Plus Team for Anti-aging Biotechnology and Industry, Department of Convergence Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea.

Moe Kyaw Myint (MK)

Department of Medical Research Pyin Oo Lwin Branch, Pyin Oo Lwin, Myanmar.

Khin Saw Aye (KS)

Department of Medical Research Pyin Oo Lwin Branch, Pyin Oo Lwin, Myanmar.

Woon-Mok Sohn (WM)

Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea.

Ho-Joon Shin (HJ)

Department of Microbiology, Ajou University School of Medicine, Suwon, 16499, Republic of Korea.

Tong-Soo Kim (TS)

Department of Tropical Medicine, and Inha Research Institute for Medical Sciences, Inha University College of Medicine, Incheon, 22212, Republic of Korea.

Byoung-Kuk Na (BK)

Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju, 52727, Republic of Korea. bkna@gnu.ac.kr.
BK21Plus Team for Anti-aging Biotechnology and Industry, Department of Convergence Medical Science, Gyeongsang National University, Jinju, 52727, Republic of Korea. bkna@gnu.ac.kr.

Articles similaires

Eimeria tenella Animals Antigens, Protozoan Chickens Genetic Variation

Detailing organelle division and segregation in Plasmodium falciparum.

Julie M J Verhoef, Cas Boshoven, Felix Evers et al.
1.00
Plasmodium falciparum Mitochondria Apicoplasts Humans Animals
Indoleacetic Acids Babesia Gene Knockdown Techniques Protozoan Proteins Oryza
Leishmania donovani Animals Antifungal Agents Mice Azoles

Classifications MeSH